163 related articles for article (PubMed ID: 37244822)
21. Paxillin: application of immunohistochemistry to the diagnosis of chromophobe renal cell carcinoma and oncocytoma.
Kuroda N; Guo L; Toi M; Naruse K; Miyazaki E; Hayashi Y; Yoshikawa C; Ashida S; Shuin T; Enzan H
Appl Immunohistochem Mol Morphol; 2001 Dec; 9(4):315-8. PubMed ID: 11759057
[TBL] [Abstract][Full Text] [Related]
22. Recommendations for the Management of Rare Kidney Cancers.
Giles RH; Choueiri TK; Heng DY; Albiges L; Hsieh JJ; Linehan WM; Pal S; Maskens D; Paseman B; Jonasch E; Malouf G; Molina AM; Pickering L; Shuch B; Srinivas S; Srinivasan R; Tannir NM; Bex A
Eur Urol; 2017 Dec; 72(6):974-983. PubMed ID: 28720391
[TBL] [Abstract][Full Text] [Related]
23. Adult Renal Cell Carcinoma: A Review of Established Entities from Morphology to Molecular Genetics.
Hirsch MS; Signoretti S; Dal Cin P
Surg Pathol Clin; 2015 Dec; 8(4):587-621. PubMed ID: 26612217
[TBL] [Abstract][Full Text] [Related]
24. Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia.
Tickoo SK; dePeralta-Venturina MN; Harik LR; Worcester HD; Salama ME; Young AN; Moch H; Amin MB
Am J Surg Pathol; 2006 Feb; 30(2):141-53. PubMed ID: 16434887
[TBL] [Abstract][Full Text] [Related]
25. Chemotherapy for non-clear-cell renal cell carcinoma.
David KA; Milowsky MI; Nanus DM
Clin Genitourin Cancer; 2006 Mar; 4(4):263-8. PubMed ID: 16729909
[TBL] [Abstract][Full Text] [Related]
26. How New Developments Impact Diagnosis in Existing Renal Neoplasms.
Akgul M; Williamson SR
Surg Pathol Clin; 2022 Dec; 15(4):695-711. PubMed ID: 36344184
[TBL] [Abstract][Full Text] [Related]
27. Accuracy of fine needle aspiration in distinguishing subtypes of renal cell carcinoma.
Renshaw AA; Lee KR; Madge R; Granter SR
Acta Cytol; 1997; 41(4):987-94. PubMed ID: 9250289
[TBL] [Abstract][Full Text] [Related]
28. Assessing Genomic Copy Number Alterations as Best Practice for Renal Cell Neoplasia: An Evidence-Based Review from the Cancer Genomics Consortium Workgroup.
Liu YJ; Houldsworth J; Emmadi R; Dyer L; Wolff DJ
Cancer Genet; 2020 Jun; 244():40-54. PubMed ID: 32434132
[TBL] [Abstract][Full Text] [Related]
29. Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications.
Kuehn A; Paner GP; Skinnider BF; Cohen C; Datta MW; Young AN; Srigley JR; Amin MB
Am J Surg Pathol; 2007 Oct; 31(10):1528-33. PubMed ID: 17895753
[TBL] [Abstract][Full Text] [Related]
30. Validation of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinomas.
Mosquera JM; Dal Cin P; Mertz KD; Perner S; Davis IJ; Fisher DE; Rubin MA; Hirsch MS
Diagn Mol Pathol; 2011 Sep; 20(3):129-37. PubMed ID: 21817901
[TBL] [Abstract][Full Text] [Related]
31. [Renal cell carcinoma diagnosis and prognosis within the context of the WHO classification 2016].
Zimpfer A; Glass Ä; Zettl H; Maruschke M; Hakenberg OW; Erbersdobler A
Urologe A; 2019 Sep; 58(9):1057-1065. PubMed ID: 31093717
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical diagnosis of renal neoplasms.
Truong LD; Shen SS
Arch Pathol Lab Med; 2011 Jan; 135(1):92-109. PubMed ID: 21204715
[TBL] [Abstract][Full Text] [Related]
33. Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT.
Young JR; Margolis D; Sauk S; Pantuck AJ; Sayre J; Raman SS
Radiology; 2013 May; 267(2):444-53. PubMed ID: 23382290
[TBL] [Abstract][Full Text] [Related]
34. Prognostic Factors for Renal Cell Carcinoma Subtypes Diagnosed According to the 2016 WHO Renal Tumor Classification: a Study Involving 928 Patients.
Kuthi L; Jenei A; Hajdu A; Németh I; Varga Z; Bajory Z; Pajor L; Iványi B
Pathol Oncol Res; 2017 Jul; 23(3):689-698. PubMed ID: 28032311
[TBL] [Abstract][Full Text] [Related]
35. Renal cell carcinoma and mimics: pathologic primer for radiologists.
Bai X; Wu CL
AJR Am J Roentgenol; 2012 Jun; 198(6):1289-93. PubMed ID: 22623540
[TBL] [Abstract][Full Text] [Related]
36. Renal Cell Carcinoma Occurring in Patients With Prior Neuroblastoma: A Heterogenous Group of Neoplasms.
Falzarano SM; McKenney JK; Montironi R; Eble JN; Osunkoya AO; Guo J; Zhou S; Xiao H; Dhanasekaran SM; Shukla S; Mehra R; Magi-Galluzzi C
Am J Surg Pathol; 2016 Jul; 40(7):989-97. PubMed ID: 26975037
[TBL] [Abstract][Full Text] [Related]
37. Characteristics of the Peritumoral Pseudocapsule Vary Predictably With Histologic Subtype of T1 Renal Neoplasms.
Jacob JM; Williamson SR; Gondim DD; Leese JA; Terry C; Grignon DJ; Boris RS
Urology; 2015 Nov; 86(5):956-61. PubMed ID: 26126697
[TBL] [Abstract][Full Text] [Related]
38. [Chromophobe renal cell carcinoma - case report].
Krawiec K; Marks P; Różański W; Lipiński M
Pol Merkur Lekarski; 2015 Feb; 38(224):100-3. PubMed ID: 25771519
[TBL] [Abstract][Full Text] [Related]
39. Chromosomal abnormalities in renal cell carcinoma variants detected by Urovysion fluorescence in situ hybridization on paraffin-embedded tissue.
Reid-Nicholson MD; Motiwala N; Drury SC; Peiper SC; Terris MK; Waller JL; Ramalingam P
Ann Diagn Pathol; 2011 Feb; 15(1):37-45. PubMed ID: 21238914
[TBL] [Abstract][Full Text] [Related]
40. Evolving role of cytoreductive nephrectomy in metastatic renal cell carcinoma of variant histology.
Alhalabi O; Karam JA; Tannir NM
Curr Opin Urol; 2019 Sep; 29(5):521-525. PubMed ID: 31305271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
